- Home
- SUNS vs ME Comparison
SUNS vs ME Comparison
Compare SUNS & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUNS
- ME
- Stock Information
- Founded
- SUNS 2023
- ME 2006
- Country
- SUNS United States
- ME United States
- Employees
- SUNS N/A
- ME N/A
- Industry
- SUNS Real Estate Investment Trusts
- ME Precision Instruments
- Sector
- SUNS Real Estate
- ME Health Care
- Exchange
- SUNS Nasdaq
- ME Nasdaq
- Market Cap
- SUNS 104.3M
- ME 113.9M
- IPO Year
- SUNS N/A
- ME N/A
- Fundamental
- Price
- SUNS $13.59
- ME $3.27
- Analyst Decision
- SUNS Buy
- ME Hold
- Analyst Count
- SUNS 1
- ME 1
- Target Price
- SUNS $17.50
- ME $9.40
- AVG Volume (30 Days)
- SUNS 67.3K
- ME 322.1K
- Earning Date
- SUNS 02-15-2025
- ME 02-05-2025
- Dividend Yield
- SUNS 4.64%
- ME N/A
- EPS Growth
- SUNS N/A
- ME N/A
- EPS
- SUNS 0.03
- ME N/A
- Revenue
- SUNS $734,226.00
- ME $193,260,000.00
- Revenue This Year
- SUNS N/A
- ME $21.93
- Revenue Next Year
- SUNS N/A
- ME $17.31
- P/E Ratio
- SUNS $133.71
- ME N/A
- Revenue Growth
- SUNS N/A
- ME N/A
- 52 Week Low
- SUNS $8.11
- ME $2.66
- 52 Week High
- SUNS $15.74
- ME $19.34
- Technical
- Relative Strength Index (RSI)
- SUNS N/A
- ME 41.70
- Support Level
- SUNS N/A
- ME $3.03
- Resistance Level
- SUNS N/A
- ME $3.50
- Average True Range (ATR)
- SUNS 0.00
- ME 0.33
- MACD
- SUNS 0.00
- ME 0.02
- Stochastic Oscillator
- SUNS 0.00
- ME 21.05
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.